My guess as to why most use the 1:10 for a potential RS, is that a current sp of 50 cents, that is what it would take to get the sp to $5. That is a magic number below which certain institutions or whatever cannot purchase a stock.
Many of us abhor a RS split and I don't see why, if the goal is to sell V to a BP, it is necessary to remain listed on the Nasdaq. If a highly effective drug that a BP was interested in was owned by a private company I assume they would still be able to consummate a deal assuming terms were agreable to both parties.
I mean I suppose but they have been talking about Italy for months and still nothing. And what makes you think sarissa will buy any shares they have not said a word in like a year? Remember when brave was going to be a catalyst? Denner has done nothing but destroy shareholder value period. Until he proves otherwise he is a disaster.
Extended timeline from Nasdaq is May, so there are a few catalyst that would improve SP. Italy, appears imminent with the hiring of personnel France may be approved by then (and we know it's a slow slog to increase revenue but it's the approval that matters first The cancer study results might be positive and posted per North40000 timeline Initiate BB versus RS Sarissa purchase additional share
Market Data 
Markets 
AI
